Immunosuppressant prescription pattern and trend in kidney transplantation: A multicenter study in Korea

Ji Yeun Chang, Jihyun Yu, Byung Ha Chung, Jaeseok Yang, Sung Joo Kim, Chan Duck Kim, Sang Ho Lee, Jong Soo Lee, Joong Kyung Kim, Cheol Woong Jung, Chang Kwon Oh, Chul Woo Yang

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Background: The actual prescription pattern of immunosuppressive agents in kidney transplantation is unclear. Methods: We investigated the pattern and trend of immunosuppressive treatment for kidney transplant patients in South Korea. A total of 636 patients at nine transplant centers were enrolled and followed for one year. We reviewed medical records and evaluated induction therapy, as well as the changing pattern and cause of maintenance therapy. Results Most patients (n = 621, 97.6%) received induction therapy often comprising basiliximab (n = 542, 85.2%). The triple therapy including calcineurin inhibitor, mycophenolic acid, and steroids was the major initial maintenance immunosuppression (n = 518, 81.4%), but its proportion decreased by 14% (81.4% to 67.5%) after 1 year. Almost 40% of patients changed immunosuppressive regimen during the 1-year follow-up, most often at an early period (60.2% within the first 4 months). The primary reason for the change was gastrointestinal discomfort (n = 113, 29.8%), followed by infection (112, 29.6%). The most common changing pattern was mycophenolic acid withdrawal (n = 155, 39.1%). Conclusion: The initial immunosuppressive regimen is prone to change within the first year of kidney transplantation. Further studies are needed to evaluate the benefits and risks in patients who changed immunosuppressants.

Original languageEnglish
Article numbere0183826
JournalPLoS One
Volume12
Issue number8
DOIs
Publication statusPublished - 2017 Aug 1

Fingerprint

immunosuppressive agents
kidney transplant
Immunosuppressive Agents
Korea
Kidney Transplantation
Multicenter Studies
Prescriptions
Korean Peninsula
Mycophenolic Acid
therapeutics
Transplants
Therapeutics
Republic of Korea
acids
immunosuppression
South Korea
Immunosuppression
steroids
Medical Records
Steroids

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)
  • Agricultural and Biological Sciences(all)

Cite this

Chang, J. Y., Yu, J., Chung, B. H., Yang, J., Kim, S. J., Kim, C. D., ... Yang, C. W. (2017). Immunosuppressant prescription pattern and trend in kidney transplantation: A multicenter study in Korea. PLoS One, 12(8), [e0183826]. https://doi.org/10.1371/journal.pone.0183826

Immunosuppressant prescription pattern and trend in kidney transplantation : A multicenter study in Korea. / Chang, Ji Yeun; Yu, Jihyun; Chung, Byung Ha; Yang, Jaeseok; Kim, Sung Joo; Kim, Chan Duck; Lee, Sang Ho; Lee, Jong Soo; Kim, Joong Kyung; Jung, Cheol Woong; Oh, Chang Kwon; Yang, Chul Woo.

In: PLoS One, Vol. 12, No. 8, e0183826, 01.08.2017.

Research output: Contribution to journalArticle

Chang, JY, Yu, J, Chung, BH, Yang, J, Kim, SJ, Kim, CD, Lee, SH, Lee, JS, Kim, JK, Jung, CW, Oh, CK & Yang, CW 2017, 'Immunosuppressant prescription pattern and trend in kidney transplantation: A multicenter study in Korea', PLoS One, vol. 12, no. 8, e0183826. https://doi.org/10.1371/journal.pone.0183826
Chang, Ji Yeun ; Yu, Jihyun ; Chung, Byung Ha ; Yang, Jaeseok ; Kim, Sung Joo ; Kim, Chan Duck ; Lee, Sang Ho ; Lee, Jong Soo ; Kim, Joong Kyung ; Jung, Cheol Woong ; Oh, Chang Kwon ; Yang, Chul Woo. / Immunosuppressant prescription pattern and trend in kidney transplantation : A multicenter study in Korea. In: PLoS One. 2017 ; Vol. 12, No. 8.
@article{d85bd14a1d074c3684262916730182a0,
title = "Immunosuppressant prescription pattern and trend in kidney transplantation: A multicenter study in Korea",
abstract = "Background: The actual prescription pattern of immunosuppressive agents in kidney transplantation is unclear. Methods: We investigated the pattern and trend of immunosuppressive treatment for kidney transplant patients in South Korea. A total of 636 patients at nine transplant centers were enrolled and followed for one year. We reviewed medical records and evaluated induction therapy, as well as the changing pattern and cause of maintenance therapy. Results Most patients (n = 621, 97.6{\%}) received induction therapy often comprising basiliximab (n = 542, 85.2{\%}). The triple therapy including calcineurin inhibitor, mycophenolic acid, and steroids was the major initial maintenance immunosuppression (n = 518, 81.4{\%}), but its proportion decreased by 14{\%} (81.4{\%} to 67.5{\%}) after 1 year. Almost 40{\%} of patients changed immunosuppressive regimen during the 1-year follow-up, most often at an early period (60.2{\%} within the first 4 months). The primary reason for the change was gastrointestinal discomfort (n = 113, 29.8{\%}), followed by infection (112, 29.6{\%}). The most common changing pattern was mycophenolic acid withdrawal (n = 155, 39.1{\%}). Conclusion: The initial immunosuppressive regimen is prone to change within the first year of kidney transplantation. Further studies are needed to evaluate the benefits and risks in patients who changed immunosuppressants.",
author = "Chang, {Ji Yeun} and Jihyun Yu and Chung, {Byung Ha} and Jaeseok Yang and Kim, {Sung Joo} and Kim, {Chan Duck} and Lee, {Sang Ho} and Lee, {Jong Soo} and Kim, {Joong Kyung} and Jung, {Cheol Woong} and Oh, {Chang Kwon} and Yang, {Chul Woo}",
year = "2017",
month = "8",
day = "1",
doi = "10.1371/journal.pone.0183826",
language = "English",
volume = "12",
journal = "PLoS One",
issn = "1932-6203",
publisher = "Public Library of Science",
number = "8",

}

TY - JOUR

T1 - Immunosuppressant prescription pattern and trend in kidney transplantation

T2 - A multicenter study in Korea

AU - Chang, Ji Yeun

AU - Yu, Jihyun

AU - Chung, Byung Ha

AU - Yang, Jaeseok

AU - Kim, Sung Joo

AU - Kim, Chan Duck

AU - Lee, Sang Ho

AU - Lee, Jong Soo

AU - Kim, Joong Kyung

AU - Jung, Cheol Woong

AU - Oh, Chang Kwon

AU - Yang, Chul Woo

PY - 2017/8/1

Y1 - 2017/8/1

N2 - Background: The actual prescription pattern of immunosuppressive agents in kidney transplantation is unclear. Methods: We investigated the pattern and trend of immunosuppressive treatment for kidney transplant patients in South Korea. A total of 636 patients at nine transplant centers were enrolled and followed for one year. We reviewed medical records and evaluated induction therapy, as well as the changing pattern and cause of maintenance therapy. Results Most patients (n = 621, 97.6%) received induction therapy often comprising basiliximab (n = 542, 85.2%). The triple therapy including calcineurin inhibitor, mycophenolic acid, and steroids was the major initial maintenance immunosuppression (n = 518, 81.4%), but its proportion decreased by 14% (81.4% to 67.5%) after 1 year. Almost 40% of patients changed immunosuppressive regimen during the 1-year follow-up, most often at an early period (60.2% within the first 4 months). The primary reason for the change was gastrointestinal discomfort (n = 113, 29.8%), followed by infection (112, 29.6%). The most common changing pattern was mycophenolic acid withdrawal (n = 155, 39.1%). Conclusion: The initial immunosuppressive regimen is prone to change within the first year of kidney transplantation. Further studies are needed to evaluate the benefits and risks in patients who changed immunosuppressants.

AB - Background: The actual prescription pattern of immunosuppressive agents in kidney transplantation is unclear. Methods: We investigated the pattern and trend of immunosuppressive treatment for kidney transplant patients in South Korea. A total of 636 patients at nine transplant centers were enrolled and followed for one year. We reviewed medical records and evaluated induction therapy, as well as the changing pattern and cause of maintenance therapy. Results Most patients (n = 621, 97.6%) received induction therapy often comprising basiliximab (n = 542, 85.2%). The triple therapy including calcineurin inhibitor, mycophenolic acid, and steroids was the major initial maintenance immunosuppression (n = 518, 81.4%), but its proportion decreased by 14% (81.4% to 67.5%) after 1 year. Almost 40% of patients changed immunosuppressive regimen during the 1-year follow-up, most often at an early period (60.2% within the first 4 months). The primary reason for the change was gastrointestinal discomfort (n = 113, 29.8%), followed by infection (112, 29.6%). The most common changing pattern was mycophenolic acid withdrawal (n = 155, 39.1%). Conclusion: The initial immunosuppressive regimen is prone to change within the first year of kidney transplantation. Further studies are needed to evaluate the benefits and risks in patients who changed immunosuppressants.

UR - http://www.scopus.com/inward/record.url?scp=85028571532&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85028571532&partnerID=8YFLogxK

U2 - 10.1371/journal.pone.0183826

DO - 10.1371/journal.pone.0183826

M3 - Article

C2 - 28846737

AN - SCOPUS:85028571532

VL - 12

JO - PLoS One

JF - PLoS One

SN - 1932-6203

IS - 8

M1 - e0183826

ER -